- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Elscint's second-quarter results sag
Elscint's second-quarter results sag It was a case of good newsand bad news this month for Elscint Ltd., which reported financialresults for the second quarter (end-June). On one hand, the Israelivendor reported that sales of its CT Twin family of
Elscint's second-quarter results sag It was a case of good newsand bad news this month for Elscint Ltd., which reported financialresults for the second quarter (end-June). On one hand, the Israelivendor reported that sales of its CT Twin family of scanners werestronger than expected. On the other, overall revenues for thequarter dropped 9% due to the ongoing slump in nuclear medicinesales in North America.
Revenues for the second quarter of 1994 totaled $54.7 million,down from the $60.3 million recorded in the same period last year.Net income was down sharply, to $2.7 million from $7.2 millionin last year's second quarter, a drop of 63%.
Depressed market conditions in North America have caused intensecompetition and aggressive pricing, which have impacted margins,according Shmuel Parag, president and CEO of Haifa-based Elscint.The nuclear medicine market is down 25% in the first two quartersof 1994, according to data from the National Electrical ManufacturersAssociation, Parag said.
The company saw a 10% increase in the order backlog for itsCT-Twin family, however. CT scanner sales, as well as cost-cuttingmeasures Elscint has already implemented, should improve the company'sresults beginning in the fourth quarter of this year.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
